573 related articles for article (PubMed ID: 11583974)
1. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis.
Yang J; Liu Y
Am J Pathol; 2001 Oct; 159(4):1465-75. PubMed ID: 11583974
[TBL] [Abstract][Full Text] [Related]
2. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis.
Yang J; Liu Y
J Am Soc Nephrol; 2002 Jan; 13(1):96-107. PubMed ID: 11752026
[TBL] [Abstract][Full Text] [Related]
3. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation.
Strutz F; Zeisberg M; Ziyadeh FN; Yang CQ; Kalluri R; Müller GA; Neilson EG
Kidney Int; 2002 May; 61(5):1714-28. PubMed ID: 11967021
[TBL] [Abstract][Full Text] [Related]
4. MAD2B promotes tubular epithelial-to-mesenchymal transition and renal tubulointerstitial fibrosis via Skp2.
Tang H; Fan D; Lei CT; Ye C; Gao P; Chen S; Meng XF; Su H; Zhang C
J Mol Med (Berl); 2016 Nov; 94(11):1297-1307. PubMed ID: 27488450
[TBL] [Abstract][Full Text] [Related]
5. TGFbeta1 induces epithelial-mesenchymal transition, but not myofibroblast transdifferentiation of human kidney tubular epithelial cells in primary culture.
Forino M; Torregrossa R; Ceol M; Murer L; Della Vella M; Del Prete D; D'Angelo A; Anglani F
Int J Exp Pathol; 2006 Jun; 87(3):197-208. PubMed ID: 16709228
[TBL] [Abstract][Full Text] [Related]
6. Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation.
Cheng S; Lovett DH
Am J Pathol; 2003 Jun; 162(6):1937-49. PubMed ID: 12759250
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro.
Fan JM; Ng YY; Hill PA; Nikolic-Paterson DJ; Mu W; Atkins RC; Lan HY
Kidney Int; 1999 Oct; 56(4):1455-67. PubMed ID: 10504497
[TBL] [Abstract][Full Text] [Related]
8. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.
Kang MK; Park SH; Choi YJ; Shin D; Kang YH
J Mol Med (Berl); 2015 Jul; 93(7):759-72. PubMed ID: 26062793
[TBL] [Abstract][Full Text] [Related]
9. The regulatory peptide apelin: a novel inhibitor of renal interstitial fibrosis.
Wang LY; Diao ZL; Zhang DL; Zheng JF; Zhang QD; Ding JX; Liu WH
Amino Acids; 2014 Dec; 46(12):2693-704. PubMed ID: 25164121
[TBL] [Abstract][Full Text] [Related]
10. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
Zeisberg M; Hanai J; Sugimoto H; Mammoto T; Charytan D; Strutz F; Kalluri R
Nat Med; 2003 Jul; 9(7):964-8. PubMed ID: 12808448
[TBL] [Abstract][Full Text] [Related]
11. Arctigenin suppresses transforming growth factor-β1-induced expression of monocyte chemoattractant protein-1 and the subsequent epithelial-mesenchymal transition through reactive oxygen species-dependent ERK/NF-κB signaling pathway in renal tubular epithelial cells.
Li A; Wang J; Zhu D; Zhang X; Pan R; Wang R
Free Radic Res; 2015; 49(9):1095-113. PubMed ID: 25968940
[TBL] [Abstract][Full Text] [Related]
12. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis.
Jinde K; Nikolic-Paterson DJ; Huang XR; Sakai H; Kurokawa K; Atkins RC; Lan HY
Am J Kidney Dis; 2001 Oct; 38(4):761-9. PubMed ID: 11576879
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition.
Slattery C; Campbell E; McMorrow T; Ryan MP
Am J Pathol; 2005 Aug; 167(2):395-407. PubMed ID: 16049326
[TBL] [Abstract][Full Text] [Related]
14. Notch mediated epithelial to mesenchymal transformation is associated with increased expression of the Snail transcription factor.
Saad S; Stanners SR; Yong R; Tang O; Pollock CA
Int J Biochem Cell Biol; 2010 Jul; 42(7):1115-22. PubMed ID: 20348013
[TBL] [Abstract][Full Text] [Related]
15. The role of tubular epithelial-mesenchymal transition in progressive kidney disease.
Burns WC; Kantharidis P; Thomas MC
Cells Tissues Organs; 2007; 185(1-3):222-31. PubMed ID: 17587828
[TBL] [Abstract][Full Text] [Related]
16. Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy.
Tan X; Li Y; Liu Y
J Am Soc Nephrol; 2006 Dec; 17(12):3382-93. PubMed ID: 17082242
[TBL] [Abstract][Full Text] [Related]
17. Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy.
Yang J; Liu Y
Am J Physiol Renal Physiol; 2003 Feb; 284(2):F349-57. PubMed ID: 12529273
[TBL] [Abstract][Full Text] [Related]
18. Opposite role of CD44-standard and CD44-variant-3 in tubular injury and development of renal fibrosis during chronic obstructive nephropathy.
Rampanelli E; Rouschop KM; Claessen N; Teske GJ; Pals ST; Leemans JC; Florquin S
Kidney Int; 2014 Sep; 86(3):558-69. PubMed ID: 24717295
[TBL] [Abstract][Full Text] [Related]
19. Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells.
Lan HY
Curr Opin Nephrol Hypertens; 2003 Jan; 12(1):25-9. PubMed ID: 12496662
[TBL] [Abstract][Full Text] [Related]
20. miR-141 regulates TGF-β1-induced epithelial-mesenchymal transition through repression of HIPK2 expression in renal tubular epithelial cells.
Huang Y; Tong J; He F; Yu X; Fan L; Hu J; Tan J; Chen Z
Int J Mol Med; 2015 Feb; 35(2):311-8. PubMed ID: 25421593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
